Atlas Trials

First-in-Human Study of BCX9930 in Healthy Volunteers and Patients With PNH

Clinical trial NCT04330534 · COMPLETED

Trial details

NCT number
NCT04330534
Sponsor
BioCryst Pharmaceuticals
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Paroxysmal Nocturnal Hemoglobinuria
Start date
2020-03-03
Primary completion
2020-11-11
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.